Developer docs
API playgroundTry for free, no card

Search company profiles

Remedy

Full company profile

uuid0000f22

Namestring
Remedy
Legal namestring
Remedy Entertainment Oyj
Websiteurl
myremedy.com
Company typeenum
Public
Founded yearint
1995
Descriptiontext

Remedy is a private, for-profit on-demand urgent and primary care service headquartered in Austin, Texas, founded in 2015 by Jeremy Gabrysch. The company operates with 11-50 employees and provides consumers with accessible urgent and primary care through an on-demand delivery model that emphasizes innovative care access. The firmographic and short_description explicitly position the company in the on-demand healthcare delivery category, serving individual patients seeking timely access to non-emergency clinical services.

The company has raised approximately $12.5 million in disclosed equity funding across four rounds between 2016 and 2019, with Sante Ventures leading the largest round ($10M, June 2019) and Praxis participating in an earlier round ($1.76M, 2017). An earlier seed round of $750,000 (February 2016) and an undisclosed JF2 Capital Partners engagement (April 2018) round out the capital history. The leadership team is composed of founder and CEO Jeremy Gabrysch, Chief Strategy Officer James Coan, and CFO Satish Jajodia, suggesting an executive structure oriented around operations and financial discipline rather than purely clinical leadership.

The business model centers on direct service delivery to patients in a single metropolitan market, with revenue mechanics typical of on-demand primary and urgent care providers (per-visit fees and/or direct-pay or insurance-reimbursed clinical services). No public pricing model, payer contracts, enterprise customer logos, or partnership distribution channels specific to the healthcare Remedy entity are documented in the source data. The company's website domain (myremedy.com) is presently listed for sale by a third-party marketplace, which signals potential discontinuity in the company's web presence or operating status and represents a material diligence flag. No AI/ML, proprietary clinical technology, or product differentiation signals are documented in the input data, and no recent funding, expansion, or product launch activity has been disclosed since 2019.

(Note on data heterogeneity: the input contains additional data blocks referencing a dermatologist-created skincare brand called "Remedy Science" founded by Dr. Muneeb Shah and launched at Target in December 2025, and a separate publicly listed Finnish video game developer called Remedy Entertainment Oyj. These entities are distinct from the Austin-based on-demand care company described above and are not merged into this analysis.)

Short descriptiontext

Remedy is a private, Austin-based on-demand urgent and primary care service founded in 2015, delivering accessible clinical care to individual patients and having raised approximately $12.5M in disclosed equity funding through 2019.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
urgent care services, primary care services, on-demand healthcare, mobile healthcare, telehealth services
Industry1 code
PRIMARYHLALAAAD
Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
NAICS code2 codes
  • Offices of Physicians62111
  • Home Health Care Services62161
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Home Health Care Services8082
Product category
On-Demand Urgent and Primary Care
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Skincare Product Sales
TypeOne Time License
Description

Direct-to-consumer and retail sales of dermatologist-created skincare products through Target's nationwide retail presence of nearly 2,000 stores, generating expected revenues between $30 million and $40 million in the first year at Target.

morningstar.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Technology or R&D
Pricing details1 tier
1Mass-market accessible skincare products
ModelUnit Pricing
Notes

Products designed to be accessible at mainstream retail price points, challenging traditional industry pricing strategies.

morningstar.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Remedy provides on-demand urgent and primary care services with a focus on innovative delivery of care. Founded in 2015 and headquartered in Austin, Texas, the company operates a private, for-profit healthcare service aimed at making urgent and primary care more accessible to consumers through an on-demand model.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 207% growth from first to second year
+1 more record
Product overview1 text field

Remedy is a Finnish video game development studio offering a portfolio of interconnected supernatural action-adventure games. The core products include Control (the original supernatural game), Control Resonant (an upcoming 2026 sequel with New York City setting), and Alan Wake, all unified under the Remedy Connected Universe. The company develops games featuring reality-warping gameplay, immersive world-building with detailed codex entries, and interconnected lore across multiple titles. Their games are available on major gaming platforms including PlayStation and Xbox consoles.

Product and service2 records
1On-Demand Urgent Care
CategoryUrgent Care
2On-Demand Primary Care
CategoryPrimary Care
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-12-28
Description

Remedy launched its first retail partnership with Target on December 28, 2025, in nearly 2,000 stores nationwide. This partnership represents the brand's primary retail distribution channel and marks a significant milestone in making dermatologist-designed skincare accessible to mainstream consumers through Target's retail scale.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Provides in-home urgent and acute care delivered by clinicians, directly comparable to Remedy's on-demand urgent and primary care service model.

TypeDirect peer
Description

Operates a hybrid urgent care and primary care platform combining virtual and in-person visits, closely mirroring Remedy's on-demand care delivery model.

TypeDirect peer
Description

On-demand urgent care and primary care clinic network with same-day scheduling, a comparable consumer-facing urgent care delivery model.

4Heal
TypeDirect peer
Description

Doctor house-call service delivering on-demand primary and urgent care to patients at home, directly comparable to Remedy's physician-led on-demand model.

TypeDirect peer
Description

Membership-based preventive primary care with technology-enabled physician visits, a comparable innovative-delivery primary care model.

TypeBroad incumbent
Description

Large-scale membership primary care platform offering on-demand in-person and virtual visits; an incumbent in the same category Remedy competes in.

TypeBroad incumbent
Description

Virtual urgent care and primary care platform serving employer and health plan populations; a comparable on-demand virtual care service.

TypeDirect peer
Description

Members-only 24/7 urgent care provider offering on-demand physician access, similar to Remedy's premium on-demand care positioning.

TypeEmerging player
Description

Care-navigation and on-demand virtual care platform connecting consumers to clinicians, overlapping with Remedy's care-coordination value proposition.

10Ro
TypeBroad incumbent
Description

Direct-to-consumer telehealth and pharmacy platform with condition-specific virtual clinics; an incumbent in adjacent on-demand virtual care categories.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Remedy

On-Demand Urgent and Primary Caremyremedy.com

Remedy is a private, Austin-based on-demand urgent and primary care service founded in 2015, delivering accessible clinical care to individual patients and having raised approximately $12.5M in disclosed equity funding through 2019.

What Remedy does

Remedy is a private, for-profit on-demand urgent and primary care service headquartered in Austin, Texas, founded in 2015 by Jeremy Gabrysch. The company operates with 11-50 employees and provides consumers with accessible urgent and primary care through an on-demand delivery model that emphasizes innovative care access. The firmographic and short_description explicitly position the company in the on-demand healthcare delivery category, serving individual patients seeking timely access to non-emergency clinical services.

The company has raised approximately $12.5 million in disclosed equity funding across four rounds between 2016 and 2019, with Sante Ventures leading the largest round ($10M, June 2019) and Praxis participating in an earlier round ($1.76M, 2017). An earlier seed round of $750,000 (February 2016) and an undisclosed JF2 Capital Partners engagement (April 2018) round out the capital history. The leadership team is composed of founder and CEO Jeremy Gabrysch, Chief Strategy Officer James Coan, and CFO Satish Jajodia, suggesting an executive structure oriented around operations and financial discipline rather than purely clinical leadership.

The business model centers on direct service delivery to patients in a single metropolitan market, with revenue mechanics typical of on-demand primary and urgent care providers (per-visit fees and/or direct-pay or insurance-reimbursed clinical services). No public pricing model, payer contracts, enterprise customer logos, or partnership distribution channels specific to the healthcare Remedy entity are documented in the source data. The company's website domain (myremedy.com) is presently listed for sale by a third-party marketplace, which signals potential discontinuity in the company's web presence or operating status and represents a material diligence flag. No AI/ML, proprietary clinical technology, or product differentiation signals are documented in the input data, and no recent funding, expansion, or product launch activity has been disclosed since 2019.

(Note on data heterogeneity: the input contains additional data blocks referencing a dermatologist-created skincare brand called "Remedy Science" founded by Dr. Muneeb Shah and launched at Target in December 2025, and a separate publicly listed Finnish video game developer called Remedy Entertainment Oyj. These entities are distinct from the Austin-based on-demand care company described above and are not merged into this analysis.)

Remedy firmographics

Firmographics
Name
Remedy
Legal name
Remedy Entertainment Oyj
Website
https://myremedy.com
Company type
Public
Founded year
1995
Operating status
Operating
Headcount range
11–50 employees
Short description
Remedy is a private, Austin-based on-demand urgent and primary care service founded in 2015, delivering accessible clinical care to individual patients and having raised approximately $12.5M in disclosed equity funding through 2019.
Ownership category
akta.pro rank

Remedy industry classification

Industry
Product category
On-Demand Urgent and Primary Care
NAICS
Offices of Physicians (62111), Home Health Care Services (62161)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Home Health Care Services (8082)
akta.pro industry
PRIMARYHLALAAAD
Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

Keywords

  • Urgent care services
  • Primary care services
  • On-demand healthcare
  • Mobile healthcare
  • Telehealth services

Where Remedy is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

Remedy business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D

Revenue model

  1. Skincare Product Sales: Direct-to-consumer and retail sales of dermatologist-created skincare products through Target's nationwide retail presence of nearly 2,000 stores, generating expected revenues between $30 million and $40 million in the first year at Target.

Pricing tiers

ModelBillingPrice
Unit Pricing—Mass-market accessible skincare products

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Remedy product offering

Product offering

Core offering

Remedy provides on-demand urgent and primary care services with a focus on innovative delivery of care. Founded in 2015 and headquartered in Austin, Texas, the company operates a private, for-profit healthcare service aimed at making urgent and primary care more accessible to consumers through an on-demand model.

Product overview

Remedy is a Finnish video game development studio offering a portfolio of interconnected supernatural action-adventure games. The core products include Control (the original supernatural game), Control Resonant (an upcoming 2026 sequel with New York City setting), and Alan Wake, all unified under the Remedy Connected Universe. The company develops games featuring reality-warping gameplay, immersive world-building with detailed codex entries, and interconnected lore across multiple titles. Their games are available on major gaming platforms including PlayStation and Xbox consoles.

Differentiator

Problem solved

Functional benefit

Products and services

  • On-Demand Urgent Care
  • On-Demand Primary Care

Quantifiable outcome

  • 207% growth from first to second year
  • +1 more outcomes

Companies that use Remedy

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Remedy technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Remedy partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • TargetcoreChannel Partner/ Reseller/ Distributor · 28 December 2025Remedy launched its first retail partnership with Target on December 28, 2025, in nearly 2,000 stores nationwide. This partnership represents the brand's primary retail distribution channel and marks a significant milestone in making dermatologist-designed skincare accessible to mainstream consumers through Target's retail scale.

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Remedy competitors and assessment

Company assessment

Direct peers

  • DispatchHealth: Provides in-home urgent and acute care delivered by clinicians, directly comparable to Remedy's on-demand urgent and primary care service model.
  • Carbon Health: Operates a hybrid urgent care and primary care platform combining virtual and in-person visits, closely mirroring Remedy's on-demand care delivery model.
  • ZoomCare: On-demand urgent care and primary care clinic network with same-day scheduling, a comparable consumer-facing urgent care delivery model.
  • Heal: Doctor house-call service delivering on-demand primary and urgent care to patients at home, directly comparable to Remedy's physician-led on-demand model.
  • Forward: Membership-based preventive primary care with technology-enabled physician visits, a comparable innovative-delivery primary care model.
  • Sollis Health: Members-only 24/7 urgent care provider offering on-demand physician access, similar to Remedy's premium on-demand care positioning.

Broad incumbents

  • One Medical (Amazon): Large-scale membership primary care platform offering on-demand in-person and virtual visits; an incumbent in the same category Remedy competes in.
  • Doctor on Demand (Included Health): Virtual urgent care and primary care platform serving employer and health plan populations; a comparable on-demand virtual care service.
  • Ro: Direct-to-consumer telehealth and pharmacy platform with condition-specific virtual clinics; an incumbent in adjacent on-demand virtual care categories.

Emerging players

  • Pager: Care-navigation and on-demand virtual care platform connecting consumers to clinicians, overlapping with Remedy's care-coordination value proposition.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Remedy social profiles

Digital presence

Remedy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Remedy leadership team

Management profile

Number of profiles

Profiles3 records

Remedy funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Remedy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Remedy

What does Remedy do?

Remedy provides on-demand urgent and primary care services with a focus on innovative delivery of care. Founded in 2015 and headquartered in Austin, Texas, the company operates a private, for-profit healthcare service aimed at making urgent and primary care more accessible to consumers through an on-demand model.

Is Remedy a public or private company?

Remedy is a public company. It is classified as venture growth investor backed and is currently operating.

When was Remedy founded?

Remedy was founded in 1995. It employs 11 to 50 people.

Where is Remedy based?

Remedy is headquartered in London, United Kingdom, in the Europe region.

How does Remedy make money?

One revenue line is on record: skincare Product Sales.

Who are Remedy's main competitors?

Direct peers on record are DispatchHealth, Carbon Health, ZoomCare, Heal, Forward and Sollis Health. Broad incumbents are One Medical (Amazon), Doctor on Demand (Included Health) and Ro. Pager is listed as an emerging player.

Does Remedy have an API?

No public API is recorded for Remedy.

What industry is Remedy in?

Remedy's product category is On-Demand Urgent and Primary Care. Its primary akta.pro industry code is HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs). Its NAICS code is 62111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
gamesradarMax Payne 1 and 2 remake is still happening, but publisher Rockstar won't let Remedy say any moreRemedy confirmed that the remake of Max Payne 1 and 2 is still in production, but the developer is unable to release more details until its publisher, Rockstar Games, provides further information. The last mention of the remakes was in 2022, and Remedy has been focusing on other projects in the meantime. The delay in updates has raised questions from investors and the media regarding the status of the project.GamesIndustry.bizRemedy reports revenue declines in Q2 and H1 as it prepares for Control Resonant launchRemedy reported revenue declines in Q2 and H1 2026 due to prior game launches and increased marketing efforts for its upcoming game Control Resonant. Despite the revenue drops, pre-orders for Resonant performed well in key markets and the company remains optimistic about its launch in September 2026.Ign'A Must-Have Day 1 Purchase': Remedy Bets Big on Control Resonant, as Alan Wake 2 Passes 3 Million SoldRemedy is focusing on promoting its upcoming game Control Resonant, which is scheduled for release on September 24 across multiple platforms and has garnered 1.5 million wishlists. Despite setbacks including declining profit, revenue, and cash flow, Remedy's priority is to build its franchise and support its existing titles like Alan Wake 2 and Max Payne remakes.KauppalehtiPÖRSSI: Helsingin pörssi matelee – Tulosjulkistajat Remedy ja Ponsse plussallaHelsingin pörssi opened slightly higher but closed flat, with Outokummun shares rising over 6% following a favorable analyst report from JPMorgan. Remedy and Ponsse shares also increased, driven by their financial results, while Seili Solutions and Posti Group experienced declines or were affected by analyst revisions.IgnControl Resonant: Exclusive Metro Fault Mission Gameplay — IGN FirstThe article discusses the gameplay and features of the upcoming video game 'Control Resonant,' a sequel to the 2019 original, developed by Remedy Entertainment, set in an alternate New York City where players navigate underground Faults to develop abilities.PR NewswireRemedy Science Launches Nationally at Target, Signaling a New Era of Straightforward, Expert-Led Dermatological SkincareREMEDY, a dermatologist-founded skincare brand created by Dr. Muneeb Shah, launched nationwide at Target on December 28, 2025, marking a major retail expansion for the challenger brand. The launch includes a complete edit of daily essentials and targeted treatments with several products seeing price reductions due to Target's scale and margin structure, positioning the brand as an accessible alternative to traditional "big beauty." Early retail indicators project REMEDY as a breakout skincare launch of the year, supported by a community of over 20 million followers who participated in selecting Target as the preferred retailer.KitGuruRemedy reveals Control Resonant, a reality-warping sequel coming in 2026Remedy announced 'Control Resonant,' a sequel set for a 2026 release that expands the franchise's scope to New York City and features a gameplay transition to a more action-oriented format. The game involves the protagonist Dylan Faden battling a cosmic entity while seeking his sister, with a focus on metaphysical environments and accessible gameplay.Game DeveloperRemedy shifting resources away from FBC: FirebreakRemedy's interim CEO Markus Mäki announced a strategic shift in resources away from the game FBC: Firebreak following poor sales and financial losses. The company posted a significant operating loss in Q3, with revenue declining by 32%, and has recognized impairments related to FBC: Firebreak. Remedy plans to focus on other projects like Control 2 and Max Payne Remake to restore profitability.Y CombinatorRemedy: AI Agents for PharmaciesRemedy, a healthcare company, is developing AI agents for pharmacies to streamline prescription refills and improve patient care. The company was founded in fall 2025 by Nikhil Devaraj and Vishnu Sreenivasan, with a team of two.FiltermagFor the First Time, Harm Reduction Gets a Naloxone of Its OwnA new naloxone product tailored for harm reduction programs was launched on August 1 by Remedy Alliance/For the People, in collaboration with Hikma Pharmaceuticals, after a previous manufacturing disruption affected access to naloxone. Remedy Alliance aims to provide over 2 million doses of this naloxone in the coming year, demonstrating a significant increase from previous distributions. The partnership marks a historic move as it is the first time naloxone is manufactured specifically for harm reduction programs, incorporating community input.